Atlas Trials

SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC

Clinical trial NCT03578874 · COMPLETED

Trial details

NCT number
NCT03578874
Sponsor
The University of Hong Kong
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2016-06-20
Primary completion
2019-04-30
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.